newsfilter
← Latest News
GlobeNewswire·

Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call

BOSTON, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare